What is the Future of Cancer Research?
Éditeur
Académie royale de Belgique
Date de publication
Collection
L'Académie en poche
Langue
français
Fiches UNIMARC
S'identifier

What is the Future of Cancer Research?

Académie royale de Belgique

L'Académie en poche

AideEAN13 : 9782803104192
  • Fichier EPUB, libre d'utilisation
  • Fichier Mobipocket, libre d'utilisation
  • Lecture en ligne, lecture en ligne
3.99

Cancer is the second leading cause of death in Europe after cardiovascular
diseases. Each year, nearly 3.5 million new cases of cancer are diagnosed in
the EU countries out of which more than 1.5 million deaths. Facing this
significant number, investment in clinical cancer research remains crucial.

It is with this perspective in mind that the European Organisation for
Research and Treatment of Cancer (EORTC) was founded in the early ‘60s to
provide patients with the best treatments. Today, the organization still
remains at the forefront of clinical cancer research.

Explaining basic and clinical research, the challenges, patient information
and rights, the role of the EORTC and research perspectives, these are all
topics that this small but dense book attempts to synthesize. Ultimately, this
book is aimed at all those directly or indirectly related to this serious
disease, patients, economic and political decision-makers, pharmaceutical
manufacturers and of course, physicians.

Françoise Meunier is one of the foremost specialists in the field of oncology.
Since 1991 she is responsible for the coordination of the scientific
activities and strategies of the EORTC. She was appointed Senior Research
Associate at the FNRS (1990) while Head of Infectious Diseases Department and
Microbiology Laboratory at the Institut Jules Bordet in Brussels. She is also
a member of the Royal Academy of Medicine of Belgium, the European Academy of
Cancer Sciences and the Scientific Committee of IMI (Innovative Medicines
Initiative) of the European Union.

S'identifier pour envoyer des commentaires.